Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.